Slashdot picks up the study, commenters flag hype risk but note rigor
3Sep 12 1:08 AM · 13d ago · 1 post · 1 source · development 3 of 3
A Slashdot post summarizing the coverage draws early commentary noting that red-light therapy claims often precede commercial hype, while acknowledging this particular study used randomization and sham controls over a full season.
nytimes.com
“It always starts with "promising results" and ends with somebody selling a $799 helmet on Instagram.”
Slashdot commenter
Larry CarrFormer BYU linebacker, subject and advocateLaurie CarrLarry Carr's wifeElisabeth WildeCo-director, TBI and Concussion Center, University of UtahPaolo CassanoDirector of Photobiomodulation, Massachusetts General/Harvard Medical School
The whole story articlespoststhe bright band is this development · numbered dots are the others · click one to jump
S